GlassScriptPhysician profile
Lee R Gonzalez
NPI 1326488909
$8,673.72
in general payments reported to CMS, 2019-2025
25 companies · $1,511 in 2025
The $1,511 reported for 2025 was more than what 81% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $137 · 2021: $463 · 2022: $534 · 2023: $840 · 2024: $4,566 · 2025: $1,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,428 · Education: $2,665 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,428.19 |
| Education | $2,664.98 |
| Travel and Lodging | $823.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,340.64 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $1,325.05 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $792.06 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $418.52 | 2021-2025 | |
| Genentech USA, INC. | $400.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $385.86 | 2021-2025 | Dupixent |
| Fujifilm Healthcare Americas Corporation | $300.63 | 2023-2024 | Fujifilm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.62 | 2022-2025 | Ofev, Stiolto Respimat, Jascayd |
| Inspire Medical Systems, INC. | $193.68 | 2024-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $180.70 | 2023-2024 | |
| Electromed, INC. | $169.93 | 2023-2025 | Smartvest |
| Grifols USA, LLC | $168.06 | 2023-2025 | Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Harmony Biosciences LLC | $114.41 | 2025 | |
| Mylan Specialty L.P. | $114.19 | 2021-2024 | Yupelri |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $97.59 | 2019 | |
| Verona Pharma, INC. | $81.31 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $60.73 | 2025 | Lumryz |
| Baxter Healthcare | $42.12 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $31.99 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Insmed, INC. | $30.10 | 2025 | Arikayce |
| Viatris Specialty LLC | $29.74 | 2025 | Yupelri |
| Lilly USA, LLC | $17.68 | 2025 | Zepbound |
| Circassia INC. | $12.58 | 2021 | |
| Philips North America LLC | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.